Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tourniquet plus tranexamic acid versus tourniquet plus vaginal misoprostol during myomectomy
PACTR202406615201194Not yet recruiting
- Sponsor
- Dr Ogwu Robinson
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of tranexamic acid and misoprostol in Fibromyoma (LM) (2 arms), sponsored by Dr Ogwu Robinson. Primary endpoint: Blood loss at surgery. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
tranexamic acidmisoprostol
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on PACTR202406615201194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202406615201194.